Microbial Identification Methods Market Report 2025

This Microbial Identification Methods market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The microbial identification methods market size has grown strongly in recent years. It will grow from $5.09 billion in 2024 to $5.5 billion in 2025 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to growth in the prevalence of infectious diseases, increased funding for research and development in diagnostics, increased focus on infection control measures in healthcare facilities, increased food safety concerns, and rising demand for microbial identification methods.

The microbial identification methods market size is expected to see strong growth in the next few years. It will grow to $7.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the growing demand for rapid microbiology testing, developments in microbial studies, growing adoption of automated systems, rising disposable incomes, and increasing government initiatives for food safety. Major trends in the forecast period include new product launches, advancements in microbial identification techniques, adoption of automated bacterial identification systems, advancements in microfluidics, robotics and nanotechnology, and strategic partnerships.

The growing prevalence of infectious diseases is expected to drive the expansion of the microbial identification methods market. Infectious diseases are illnesses caused by harmful pathogens, including viruses, bacteria, fungi, and parasites, that enter the body. Major infectious diseases include HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome), tuberculosis, malaria, and others. The rising prevalence of these diseases can be linked to factors such as antimicrobial resistance, climate change, and population growth. Microbial identification methods play a critical role in diagnosing, treating, and preventing infectious diseases by providing essential information about the pathogens responsible for infections. This helps healthcare professionals make informed decisions about patient care. For instance, in January 2023, the Government of Canada reported that 135 rabies samples were submitted in October 2022, and 159 were submitted in November 2022. Additionally, the Centers for Disease Control and Prevention (CDC) reported a 5.9% increase in tuberculosis (TB) cases in the U.S., rising from 7,874 cases in 2021 to 8,331 cases in 2022. As a result, the increasing prevalence of infectious diseases is driving the growth of the microbial identification methods market.

Key players in the microbial identification methods market are dedicated to developing innovative solutions, such as mycobacteria and fungi in vitro diagnostic (IVD) solutions, to bolster their market presence. Mycobacteria and fungi IVD solutions encompass a variety of products and technologies tailored to detect, identify, and characterize mycobacterial and fungal pathogens in clinical specimens. For instance, in April 2023, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, introduced the MALDI Biotyper IVD software, a novel mycobacteria and fungi IVD solution. This solution boasts enhanced accuracy and speed in microbial identification, leveraging MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) mass spectrometry technology. The platform enables rapid identification of mycobacteria and fungi from cultured samples within minutes, significantly reducing turnaround time compared to traditional methods. Moreover, the new solutions offer expanded databases and robust software algorithms for improved specificity and sensitivity, facilitating precise identification of a wider range of mycobacterial and fungal species.

In January 2023, Biolog Inc., a biotechnology company based in the United States, completed the acquisition of MIDI Labs and MIDI, Inc. for an undisclosed sum. Through this strategic acquisition, Biolog endeavors to bolster its capabilities in microbial identification and characterization by amalgamating MIDI's cutting-edge fatty acid methyl ester (FAME) analysis technology with its existing phenotype-based systems. This integration aims to create a more comprehensive suite of diagnostic tools. MIDI Labs, based in the US, is recognized as a pioneering force in microbial identification methods.

Major companies operating in the microbial identification methods market are Merck KGaA, Sumitomo Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, GE Healthcare, Avantor Inc., Eurofins Scientific SE, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., bioMerieux SA, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Beckman Coulter Inc., HiMedia Laboratories., Hardy Diagnostics., LuminUltra Technologies Ltd., Biolog Inc.

North America was the largest region in the microbial identification methods market in 2024. The regions covered in the microbial identification methods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial identification methods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Microbial identification methods encompass systematic approaches and laboratory techniques utilized to ascertain the identity and characteristics of microorganisms through the analysis of their phenotypic (observable traits) and genotypic (genetic) properties. These methods play a pivotal role in diagnosing infectious diseases, ensuring food and water safety, exploring microbial ecology, and devising effective treatments or preventive measures against pathogenic microorganisms.

Within the microbial identification methods market, the primary categories include genotypic, phenotypic, and proteotypic methods. Genotypic techniques entail identifying microorganisms based on their genetic composition, such as DNA or RNA sequences. Various types of these methods include bacterial identification systems, microbial enumeration systems, bacterial resistance identification systems, microbiology analyzers, and other variants utilized across diverse end-user sectors, including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, food testing laboratories, and other entities.

The microbial identification methods market research report is one of a series of new reports that provides microbial identification methods market statistics, including microbial identification methods industry global market size, regional shares, competitors with a microbial identification methods market share, detailed microbial identification methods market segments, market trends, and opportunities, and any further data you may need to thrive in the microbial identification methods industry. This microbial identification methods research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbial identification methods market consists of revenues earned by entities by providing services such as fatty acid analysis, biochemical testing, antimicrobial susceptibility testing (AST), and mass spectrometry (MS). The market value includes the value of related goods sold by the service provider or included within the service offering. The microbial identification method market also includes sales of microbial identification systems, mass spectrometry instruments, sequencing platforms, culture media and kits, and antimicrobial susceptibility testing (AST) systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.